Hamilton Thorne, Inc. is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.

Visit the Hamilton Thorne, Inc. website

Embryotech is an ISO-17025 accredited test laboratory providing services to the assisted reproductive technologies industry and laboratories, providing the latest quality control assays including MEA (Mouse Embryo Assay) that is used for toxicity and functionality testing of raw materials, media, labware, disposables and any device which may come into contact with gametes or embryos. Embryotech also offers endotoxin testing via Limulus Amebocyte Lysate Assay (LAL test) utilizing: Kinetic Turbidimetric quantitative and Gel-Clot qualitative testing. The company is also a provider of several sperm assays including Sperm Motility Index and Sperm Penetration. In addition, it is the leader in supplying all stages of fresh and cryopreserved mouse embryos as well as hamster ova to clinics and universities around the world aiding in technician training and proficiency testing.

Visit the Embryotech Laboratories website

Gynemed GmbH & Co. KG is a leading manufacturer and distributor of products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics. Gynemed offers a complete range of cell culture media for the embryology and andrology laboratory in the ART clinic. Founded in 1998, Gynemed’s has, since inception, demonstrated a commitment to quality products and services in Germany, Austria and Switzerland and is expanding across other European markets and internationally.

Visit the Gynemed website

Subscribe to Our Investor Email List